Hbk Investments L P Halozyme Therapeutics, Inc. Transaction History

Hbk Investments L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$13.94 - $17.58 $389,162 - $490,780	-27,917 Reduced 59.55%	18,959 $305,000
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $303,175 - $334,620	18,176 Added 63.33%	46,876 $852,000
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $1.09 Million - $1.31 Million	-64,359 Reduced 69.16%	28,700 $484,000
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $787,506 - $978,613	46,161 Added 98.43%	93,059 $1.82 Million
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $128,606 - $159,702	7,678 Added 19.58%	46,898 $950,000
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $461,227 - $682,428	39,220	39,220 $681,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.